ATE399551T1 - Hilfsmittel und methoden zur transdermalen applikation von felodipin - Google Patents

Hilfsmittel und methoden zur transdermalen applikation von felodipin

Info

Publication number
ATE399551T1
ATE399551T1 AT01988573T AT01988573T ATE399551T1 AT E399551 T1 ATE399551 T1 AT E399551T1 AT 01988573 T AT01988573 T AT 01988573T AT 01988573 T AT01988573 T AT 01988573T AT E399551 T1 ATE399551 T1 AT E399551T1
Authority
AT
Austria
Prior art keywords
felodipine
aids
methods
transdermal application
skin
Prior art date
Application number
AT01988573T
Other languages
English (en)
Inventor
Lino Tavares
Ihor Shevchuk
Mark Alfonso
Geraldine Marcenyac
Kirti Valia
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of ATE399551T1 publication Critical patent/ATE399551T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT01988573T 2000-10-23 2001-10-23 Hilfsmittel und methoden zur transdermalen applikation von felodipin ATE399551T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24251400P 2000-10-23 2000-10-23

Publications (1)

Publication Number Publication Date
ATE399551T1 true ATE399551T1 (de) 2008-07-15

Family

ID=22915068

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01988573T ATE399551T1 (de) 2000-10-23 2001-10-23 Hilfsmittel und methoden zur transdermalen applikation von felodipin

Country Status (9)

Country Link
EP (1) EP1328273B1 (de)
AT (1) ATE399551T1 (de)
AU (1) AU2002232755A1 (de)
CY (1) CY1108368T1 (de)
DE (1) DE60134656D1 (de)
DK (1) DK1328273T3 (de)
ES (1) ES2309107T3 (de)
PT (1) PT1328273E (de)
WO (1) WO2002034206A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10305137A1 (de) * 2003-02-07 2004-08-26 Novosis Ag Transdermale therapeutische Abgabesysteme mit einem Butenolid
ATE437634T1 (de) * 2004-01-14 2009-08-15 Lavipharm Lab Inc Transdermale abgabevorrichtung für dihydropyridin-artige calcium-antagonisten mit 2 fettsäuren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3245493A (en) * 1991-12-02 1993-06-28 Sepracor, Inc. Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
US5882676A (en) * 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
WO2000045797A1 (en) * 1999-02-02 2000-08-10 Ortho-Mcneil Pharmaceutical, Inc. Method of manufacture for transdermal matrices

Also Published As

Publication number Publication date
EP1328273A4 (de) 2004-09-22
CY1108368T1 (el) 2014-02-12
DE60134656D1 (de) 2008-08-14
WO2002034206A2 (en) 2002-05-02
ES2309107T3 (es) 2008-12-16
EP1328273B1 (de) 2008-07-02
WO2002034206A9 (en) 2003-04-17
WO2002034206A3 (en) 2002-07-18
AU2002232755A1 (en) 2002-05-06
EP1328273A2 (de) 2003-07-23
PT1328273E (pt) 2008-09-23
DK1328273T3 (da) 2008-10-20

Similar Documents

Publication Publication Date Title
ATE311849T1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
DE69613840D1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
DK1316308T3 (da) Transdermalt terapeutisk plaster med capsaicin og capsaicin-analoger
ATE312635T1 (de) Ventilanordnung
DE60142839D1 (de) Botulinum Toxin zur Behandlung von akuten Verletzungen der Skelettmuskeln
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
ATE390142T1 (de) Synergistische zusammensetzung zur behandlung von diabetes mellitus
CY1107640T1 (el) Μεθοδος για πιστοποιηση παραγοντων για τη θεραπεια διαβητη
ATE315390T1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
DE69535264D1 (de) Verfahren zur behandlung von diabetes mittels kgf
ATE515253T1 (de) Zusammensetzungen auf basis von etyllinoleat und triethylcitrat zur behandlung von seborrhöe und akne
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
PT1173201E (pt) Metodo para o tratamento de fibrose utilizando um antagonista da subunidade alfa 4 de integrina
ATE201598T1 (de) Verwendung von moxonidin zur behandlung neuropathischer schmerzen
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
DK0783307T3 (da) Anvendelse af 2,4-diaminopyrimidin-3-oxid eller et salt deraf til behandling af forstyrrelser i modning og strukturering af kollagen
DE69902520D1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
EP1557163A4 (de) Therapeutikum zur kontraktion vonschleimhaut, verfahren zur behandlung von erkrankungen von schleimhäuten,injektionsgerät und therapeutisches set
DE60134656D1 (de) Hilfsmittel und methoden zur transdermalen applikation von felodipin
ATE297739T1 (de) Endothelin-antagonisten zur behandlung von herzversagen
DE69917756D1 (de) Methoden zur behandlung von neurombedingten schmerzen
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
WO2002054996A3 (en) Terazosin transdermal device and methods
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1328273

Country of ref document: EP

REN Ceased due to non-payment of the annual fee